阿里木江·玉素甫, 阿孜姑·玉素甫, 阿不都拉·阿不来提, 冉建. 非甾体抗炎药应用于骨愈合期的疗效及安全性的Meta分析[J]. 实用临床医药杂志, 2023, 27(21): 17-24. DOI: 10.7619/jcmp.20232256
引用本文: 阿里木江·玉素甫, 阿孜姑·玉素甫, 阿不都拉·阿不来提, 冉建. 非甾体抗炎药应用于骨愈合期的疗效及安全性的Meta分析[J]. 实用临床医药杂志, 2023, 27(21): 17-24. DOI: 10.7619/jcmp.20232256
Alimujiang·YUSUFU, Azigu·YUSUFU, Abudula·ABULAITI, RAN Jian. Meta-analysis of the efficacy and safety of non-steroidal anti-inflammatory drugs in bone healing period[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 17-24. DOI: 10.7619/jcmp.20232256
Citation: Alimujiang·YUSUFU, Azigu·YUSUFU, Abudula·ABULAITI, RAN Jian. Meta-analysis of the efficacy and safety of non-steroidal anti-inflammatory drugs in bone healing period[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 17-24. DOI: 10.7619/jcmp.20232256

非甾体抗炎药应用于骨愈合期的疗效及安全性的Meta分析

Meta-analysis of the efficacy and safety of non-steroidal anti-inflammatory drugs in bone healing period

  • 摘要:
    目的 基于Meta分析方法探讨非甾体抗炎药(NSAIDs)应用于骨愈合期的疗效及安全性。
    方法 通过计算机检索PubMed、Cochrane Library、Web of science、Embase数据库和中国知网、万方、维普数据库,检索时间自建库至2022年12月,筛选出骨愈合期使用NSAIDs的随机对照试验(RCT)文献,结局指标为骨不连发生率、药物不良反应发生率、术后视觉模拟评分法(VAS)评分、骨痂出现率、骨密度、骨愈合时间(月)、骨愈合评分,应用RevMan 5.3软件进行Meta分析。
    结果 最终筛选出20篇RCT文献,共包括1 839例患者(NSAIDs组927例,非NSAIDs组912例)。Meta分析结果显示,非NSAIDs组骨不连发生率(OR=3.94, 95%CI: 2.06~7.53, P < 0.000 1)、骨痂出现率(OR=0.20, 95%CI: 0.10~0.40, P < 0.000 01)、骨密度(OR=-0.05, 95%CI: -0.06~-0.04, P < 0.000 01)、骨愈合时间(OR=1.45, 95%CI: 1.13~1.76, P < 0.000 01)、骨愈合评分(OR=-1.18, 95%CI: -1.74~-0.61, P < 0.000 1)均优于NSAIDs组,而NSAIDs组的药物不良反应发生率(OR=0.64, 95%CI: 0.48~0.87, P=0.004)、术后VAS评分(MD=-1.96, 95%CI: -3.09~-0.83, P=0.000 7)低于非NSAIDs组,差异有统计学意义。
    结论 NSAIDs应用于骨愈合围术期的镇痛效果明显,且不良反应小,然而其不可避免地会影响骨折愈合过程,因此具有骨不愈合或延迟愈合风险的患者应避免使用NSAIDs。

     

    Abstract:
    Objective To explore the efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs) in bone healing period by Meta-analysis.
    Methods PubMed, Cochrane Library, Web of science, Embase database, China National Knowledge Infrastructure, Wanfang and VIP databases were searched by computer from establishment of database until December 2022. The published randomized controlled trial(RCT) literatures treated with NSAIDs during bone healing was included. The outcome indexes included the incidence of nonunion, the incidence of adverse drug reactions, postoperative Visual Analogue Scale (VAS) score, callus formation rate, bone mineral density, bone healing time (months), and bone healing score. RevMan 5.3 software was used for Meta-analysis.
    Results A total of 20 RCT studies were included. A total of 1, 839 patients were included in this study(927 patients in NSAIDs group and 912 patients in non-NSAIDs group). Meta-analysis showed that the incidence of nonunion(OR=3.94; 95%CI, 2.06 to 7.53; P < 0.000 1), callus occurrence rate(OR=0.20; 95%CI, 0.10 to 0.40; P < 0.000 01), bone mineral density (OR=-0.05; 95%CI, -0.06 to -0.04; P < 0.000 01) and bone healing time (OR=1.45; 95%CI, 1.13 to 1.76; P < 0.000 01) and bone healing score (OR=-1.18; 95%CI, -1.74 to -0.61; P < 0.000 1) in the non-NSAIDs group were significantly better, while the incidence of adverse drug reactions (OR=0.64; 95%CI, 0.48 to 0.87; P=0.004) and postoperative VAS score (MD=-1.96; 95%CI, -3.09 to -0.83; P=0.000 7) in the NSAIDs group were lower than those in the non-NSAIDS group.
    Conclusion NSAID had obvious analgesic effect in the perioperative period of bone healing, and its adverse effects are small. However, it will inevitably affect the process of fracture healing. Therefore, it is suggested that the use of NSAIDs drugs should be avoided in patients with the risk of bone nonunion or delayed healing.

     

/

返回文章
返回